Giuseppe Ciaramella - Mar 31, 2022 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role: President & CSO
Signature: By: /s/ Christine Bellon, Attorney-in-fact
Stock symbol: BEAM
Transactions as of: Mar 31, 2022
Transactions value $: -$109,885
Form type: 4
Date filed: 4/4/2022, 08:32 PM
Previous filing: Feb 2, 2022
Next filing: Dec 20, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BEAM	Common Stock	Award	$0	+15K	+14.64%	$0.00	117K	Mar 31, 2022	Direct	F1
transaction	BEAM	Common Stock	Sale	-$110K	-1.86K	-1.58%	$59.11	116K	Mar 31, 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest in four substantially equal annual installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with the Company through each vesting date.
F2	These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain RSUs.

Content

Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest in four substantially equal annual installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with the Company through each vesting date.

These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain RSUs.